Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(14 sites)
United Kingdom
Royal Surrey NHS Foundation Trust, Royal Surrey County Hospital, Guildford, Surrey University Hospitals Coventry and Warwickshire, University Hospital Coventry, Coventry, Warwickshire Belfast Health and Social Care Trust, Belfast City Hospital, Belfast Cambridge University Hospital NHS Foundation Trust, Addenbrookes Hospital, Cambridge University Hospitals of Derby and Burton NHS Foundation Trust, Royal Derby Hospital, Derby NHS Tayside, Ninewells Hospital, Dundee Hull University Teaching Hospitals NHS Trust, Castel Hill Hospital, Hull Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds University College London Hospitals NHS Foundation Trust, University College Hospital London, London Guys & St Thomas NHS Foundation Trust, Guy's Hospital, London The Christie NHS Foundation Trust, Manchester Oxford University Hospitals NHS Trust, Churchill Hospital, Oxford Lancashire Teaching Hospitals NHS Foundation Trust, Royal Preston Hospital, Preston Velindre University NHS Trust, Velindre Cancer Centre, Whitchurch Age range
18 Years and older
Last updated November 2024